ABPI biosimilars position paper (updated)

Publication date:  05/02/2013
Publication ref: 
To support its members, the ABPI has updated the seven recommendations in its position paper on biosimilars which cover areas where action is needed by regulators, HTA agencies, NHS commissioners and NHS healthcare professionals who prescribe or dispense biosimilar medicines.

Document size: 356KB



Print this page icon Print this page
 
Please choose the subject of your enquiry from the list below:
 
Code to enter for submitting the form
Enter the above code here:
Can't read? Try different words.